Use of medicinal plants during COVID-19 pandemic in Brazil

• Published in: Scientific reports Vol. 13; no. 1; p. 16558
• Main Authors: da Silva, Alciellen Mendes, Horsth, Ana Luísa, Timóteo, Élida da Silva, Faria, Ronaldo José, Bazoni, Patrícia Silva, Meira, Eduardo Frizzera, dos Santos, Jéssica Barreto Ribeiro, da Silva, Michael Ruberson Ribeiro
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 02.10.2023; Nature Publishing Group; Nature Portfolio
• Subjects: 692/308/174; 692/700/478; Comorbidity; COVID-19; Frequency distribution; Herbal medicine; Humanities and Social Sciences; Medicinal plants; multidisciplinary; Pandemics; Science; Science (multidisciplinary); Brazil
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-023-43673-y

Medicinal plants are an integrative and complementary health practice widely used by the population. However, its use is not without risks. This study assessed the profile and associated factors with the traditional use of medicinal plants. To this end, a cross-sectional survey study was conducted in a southeastern Brazilian city. Descriptive analysis was performed by frequency distribution and median and interquartile range. Associated factors with the use of medicinal plants were analyzed using Poisson regression with robust variance. A total of 641 people were interviewed, of whom 258 (40.2%) reported using medicinal plants. A total of 79 distinct plants were identified, of whom Melissa officinalis (31.0%), Peumus boldus (24.4%), Mentha spicata (20.9%), Matricaria recutita L. (18.2%), Rosmarinus officinalis (17.0%), and Foeniculum vulgare (14.7%) were the most used. There were no reports of medicinal plants used to treat COVID-19. However, anxiety was the most frequently cited indication for using medicinal plants, a health condition exacerbated by the COVID-19 pandemic. Furthermore, the use of medicinal plants for treating respiratory and gastrointestinal symptoms similar to those in COVID-19 has been identified. There was an association between the use of medicinal plants and females, non-white, lower schooling, higher income, and comorbidities.